Neeraj Bharadwaj

Neeraj Bharadwaj is the Managing Director of Carlyle India Advisors Private Limited, focused on growth capital and buyout opportunities across sectors in India. Prior to joining Carlyle in 2012, Mr. Bharadwaj was a Managing Director with Accel Partners’ growth investing operation in India. Preceding that he was with Apax Partners for nearly 10 years – he was a Partner in the U.S. and subsequently Managing Director/Country Head for Apax in India, where he led the India operations.   Investments he has been involved with include Apollo Hospitals (BSE: AHEL), Jamdat (NASDAQ: JMDT), Widerthan (NASDAQ: WTHN) and others.  Previously, Mr. Bharadwaj was an engagement manager at McKinsey & Co. Mr. Bharadwaj was selected as Board Member of the Indian School of Business (ISB), a Young Global Leader of the World Economic Forum (WEF), Board Member of Olympic Gold Quest (OGQ), Member of the Harvard Business School South Asia Advisory Board, Member of the Wharton Executive Education Board, Member of the Young Presidents’ Organization and previously chaired the FICCI Committee on Private Equity & Venture Capital. 

Mr. Bharadwaj serves on the boards of Hexaware, Indegene, Nxtra Data Centers, Piramal Pharma, Sequent Scientific, Dailyhunt, CorroHealth and others.  Previously, he served on the boards of Delhivery Logistics, Global Health, Metropolis Healthcare, Visionary RCM and others. Mr. Bharadwaj holds an MBA with distinction from Harvard Business School, and graduated summa cum laude with a BS in economics from the Wharton School of the University of Pennsylvania.